Following in the footsteps of blockbuster drugs such as Ozempic and Wegovy—both powered by semaglutide—Mounjaro (approved for ...
In the case of breast cancer, women with a higher BMI do have higher rates of recurrence compared to women in the "normal" ...
There are so many false promises online when it comes to losing weight. Here are my top weight loss technologies that ...
Enrollment completed in Phase 2a CBeyondâ„¢ trial of CB1 inhibitor, nimacimab, in obesity and overweight Faster-than-expected enrollment enables full top-line Phase 2a data in late Q3/early Q4 2025, ...